Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-62,304
Closed -$3.77M – 2492
2024
Q4
$3.77M Buy
+62,304
New +$3.81M 0.02% 491
2024
Q3
– Sell
-38,093
Closed -$2.68M – 2377
2024
Q2
$2.68M Buy
38,093
+6,727
+21% +$517K 0.02% 619
2024
Q1
$2.5M Sell
31,366
-3,487
-10% -$281K 0.02% 488
2023
Q4
$3.13M Buy
+34,853
New +$3M 0.02% 462
2023
Q3
– Sell
-295,620
Closed -$30.2M – 2369
2023
Q2
$30.2M Buy
295,620
+258,286
+692% +$25.5M 0.28% 37
2023
Q1
$4.19M Buy
+37,334
New +$4.12M 0.05% 301
2022
Q1
– Sell
-2,456
Closed -$405K – 3057
2021
Q4
$405K Sell
2,456
-18,629
-88% -$3.11M ﹤0.01% 2062
2021
Q3
$3.14M Buy
+21,085
New +$3.28M 0.02% 488
2021
Q1
– Sell
-5,545
Closed -$722K – 2661
2020
Q4
$722K Buy
+5,545
New +$616K 0.01% 823
2019
Q3
– Sell
-22,804
Closed -$1.84M – 1381
2019
Q2
$1.84M Buy
22,804
+18,451
+424% +$1.46M 0.12% 186
2019
Q1
$346K Buy
+4,353
New +$334K 0.05% 266

Other funds holding APTV

HRT Financial's APTV Position: Q1 2025 in Review

HRT Financial sold out of Aptiv (APTV) in Q1 2025, closing a stake of 62,304 shares — an estimated $3.77M sold.

HRT Financial first reported a position in APTV in Q1 2019 and held it in 11 quarters. The position peaked at $30.2M in Q2 2023. 623 funds tracked by Wall St. Rank hold APTV as of Q1 2025.

  • HRT Financial reported no remaining Aptiv position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 62,304 Aptiv shares in Q1 2025, an estimated $3.77M.
  • HRT Financial first reported a position in Aptiv in Q1 2019 and held it in 11 quarters.
  • HRT Financial's Aptiv position peaked at $30.2M in Q2 2023.
  • 623 funds tracked by Wall St. Rank held Aptiv as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.